Evidence map›Paper›PMID 40444391›Full record

ReviewFuture medicinal chemistry2025

Recent advances in the investigation of the quinazoline nucleus and derivatives with potential anticancer activities.

Giorgio Antoniolli, Carmen Silvia Passos Lima, Fernando Coelho

Abstract readReview
In one paragraph

Review in Future medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Giorgio AntoniolliLaboratory of Synthesis of Natural Products and Drugs - Institute of Chemistry, University of Campinas, Campinas, SP, Brazil.
Carmen Silvia Passos LimaLaboratory of Cancer Genetics - School of Medical Sciences, University of Campinas, Campinas, SP, Brazil.
Fernando CoelhoLaboratory of Synthesis of Natural Products and Drugs - Institute of Chemistry, University of Campinas, Campinas, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDiseases such as cancer, neurodegenerative and cardiovascular disorders, and diabetes are becoming more and more common, raising global concerns about prevention and treatment. An abnormality in cell growth can lead to the formation of tumors or neoplasms. Cancer is a global public health problem and always requires further advances in the field due to the obstacles that arise during treatment. AREAS COVERED: This review explores the role of new quinazolines and their derivatives as potential anticancer agents, with a variety of biological targets. It is a current review that addresses the discovery of new molecules with the potential to go beyond just the studies covered here. ADVANTAGES, DISADVANTAGES AND FUTURE PERSPECTIVES: Studies have shown that quinazolines are not just molecules of the past, but still have enormous scope for structural modification and should be studied further than they already are. There is clear evidence that quinazolines and their derivatives have wide applicability in the fields of oncology and medicinal chemistry. The studies reported here inform and corroborate the narrative that we cannot forget that the quinazoline nucleus has a huge variety of biological activities and, among them, anticancer activity.

Indexed as

Antineoplastic AgentsNeoplasmsQuinazolinesAnimalsCell ProliferationHumansMolecular StructureAntineoplastic AgentsQuinazolinesanticancerbreast cancercancerderivativesEGFRlung cancerquinazolinequinazolinone

Identifiers

PMID40444391
PMCPMC12143717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.